299 related articles for article (PubMed ID: 12424733)
1. Role of c-Jun concentration in neuronal cell death.
Rössler OG; Steinmüller L; Giehl KM; Thiel G
J Neurosci Res; 2002 Dec; 70(5):655-64. PubMed ID: 12424733
[TBL] [Abstract][Full Text] [Related]
2. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells.
Eriksson M; Taskinen M; Leppä S
J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371
[TBL] [Abstract][Full Text] [Related]
3. Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells.
Leppä S; Eriksson M; Saffrich R; Ansorge W; Bohmann D
Mol Cell Biol; 2001 Jul; 21(13):4369-78. PubMed ID: 11390664
[TBL] [Abstract][Full Text] [Related]
4. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.
Crowe DL; Brown TN; Kim R; Smith SM; Lee MK
Mol Cell Biol Res Commun; 2000 Apr; 3(4):243-8. PubMed ID: 10891399
[TBL] [Abstract][Full Text] [Related]
5. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
6. Kainic acid-induced excitotoxicity is associated with a complex c-Fos and c-Jun response which does not preclude either cell death or survival.
Pozas E; Ballabriga J; Planas AM; Ferrer I
J Neurobiol; 1997 Sep; 33(3):232-46. PubMed ID: 9298762
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory activity of a transdominant c-jun mutant fused to the ligand binding domain of the estrogen receptor.
Kim S; Brown PH; Birrer MJ
Oncogene; 1996 Mar; 12(5):1043-53. PubMed ID: 8649795
[TBL] [Abstract][Full Text] [Related]
8. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
Dosch J; Kaina B
Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
[TBL] [Abstract][Full Text] [Related]
9. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
Chuĭkin IA; Lianguzova MS; Pospelov VA
Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
[TBL] [Abstract][Full Text] [Related]
10. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
11. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes.
Tay DL; Hoffbrand AV; Wickremasinghe GR
Exp Hematol; 1996 Feb; 24(2):277-84. PubMed ID: 8641353
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
13. Suppression of the c-Jun N-terminal kinase pathway by 17beta-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction.
Eckhoff DE; Smyth CA; Eckstein C; Bilbao G; Young CJ; Thompson JA; Contreras JL
Surgery; 2003 Aug; 134(2):169-79. PubMed ID: 12947315
[TBL] [Abstract][Full Text] [Related]
14. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
[TBL] [Abstract][Full Text] [Related]
15. Presence of distinct AP-1 dimers in normal and transformed rat hepatocytes under basal conditions and after epidermal growth factor stimulation.
Nadori F; Lardeux B; Rahmani M; Bringuier A; Durand-Schneider AM; Bernuau D
Hepatology; 1997 Dec; 26(6):1477-83. PubMed ID: 9397987
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of a dominant-negative mutant of c-Jun.
Brown PH; Chen TK; Birrer MJ
Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
[TBL] [Abstract][Full Text] [Related]
17. In vivo anergized CD4+ T cells have defective expression and function of the activating protein-1 transcription factor.
Sundstedt A; Dohlsten M
J Immunol; 1998 Dec; 161(11):5930-6. PubMed ID: 9834073
[TBL] [Abstract][Full Text] [Related]
18. MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats.
Zhong CY; Zhou YM; Douglas GC; Witschi H; Pinkerton KE
Carcinogenesis; 2005 Dec; 26(12):2187-95. PubMed ID: 16051644
[TBL] [Abstract][Full Text] [Related]
19. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
20. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells.
Pang M; Martinez AF; Fernandez I; Balkan W; Troen BR
Gene; 2007 Nov; 403(1-2):151-8. PubMed ID: 17897792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]